No abstract

No abstract

MOTIVATION Quantitative studies of cellular morphodynamics rely on extracting leading-edge velocity time series based on accurate cell segmentation from live cell imaging. However, live cell imaging has numerous challenging issues regarding accurate edge localization. Fluorescence live cell imaging produces noisy and low-contrast images due to phototoxicity and photobleaching. While phase contrast microscopy is gentle to live cells, it suffers from the halo and shade-off artifacts that cannot be handled by conventional segmentation algorithms. Here, we present a deep learning-based pipeline, termed MARS-Net (Multiple-microscopy-type-based Accurate and Robust Segmentation Network), that utilizes transfer learning and data from multiple types of microscopy to localize cell edges with high accuracy, allowing quantitative profiling of cellular morphodynamics. SUMMARY To accurately segment cell edges and quantify cellular morphodynamics from live-cell imaging data, we developed a deep learning-based pipeline termed MARS-Net (multiple-microscopy-type-based accurate and robust segmentation network). MARS-Net utilizes transfer learning and data from multiple types of microscopy to localize cell edges with high accuracy. For effective training on distinct types of live-cell microscopy, MARS-Net comprises a pretrained VGG19 encoder with U-Net decoder and dropout layers. We trained MARS-Net on movies from phase-contrast, spinning-disk confocal, and total internal reflection fluorescence microscopes. MARS-Net produced more accurate edge localization than the neural network models trained with single-microscopy-type datasets. We expect that MARS-Net can accelerate the studies of cellular morphodynamics by providing accurate pixel-level segmentation of complex live-cell datasets.

GHRH-A controls osteogenesis in smooth muscle cells by targeting cross talk between protein kinase A and nuclear factor κB (p65) and through the suppression of reactive oxygen species production that induces the gene and alkaline phosphatase. Inflammation-mediated osteogenesis is thereby blocked. GHRH-A may represent a new pharmacological strategy to regulate VC.